These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 15146243)

  • 1. A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.
    Postina R; Schroeder A; Dewachter I; Bohl J; Schmitt U; Kojro E; Prinzen C; Endres K; Hiemke C; Blessing M; Flamez P; Dequenne A; Godaux E; van Leuven F; Fahrenholz F
    J Clin Invest; 2004 May; 113(10):1456-64. PubMed ID: 15146243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress.
    Clement AB; Hanstein R; Schröder A; Nagel H; Endres K; Fahrenholz F; Behl C
    Neuroscience; 2008 Mar; 152(2):459-68. PubMed ID: 18276079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
    Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
    J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyloid at the cutting edge: activation of alpha-secretase prevents amyloidogenesis in an Alzheimer disease mouse model.
    Lichtenthaler SF; Haass C
    J Clin Invest; 2004 May; 113(10):1384-7. PubMed ID: 15146234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets.
    Evin G; Zhu A; Holsinger RM; Masters CL; Li QX
    J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. η-Secretase processing of APP inhibits neuronal activity in the hippocampus.
    Willem M; Tahirovic S; Busche MA; Ovsepian SV; Chafai M; Kootar S; Hornburg D; Evans LD; Moore S; Daria A; Hampel H; Müller V; Giudici C; Nuscher B; Wenninger-Weinzierl A; Kremmer E; Heneka MT; Thal DR; Giedraitis V; Lannfelt L; Müller U; Livesey FJ; Meissner F; Herms J; Konnerth A; Marie H; Haass C
    Nature; 2015 Oct; 526(7573):443-7. PubMed ID: 26322584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a dominant-negative form of ADAM10 in a mouse model of Alzheimer's disease.
    Schroeder A; Fahrenholz F; Schmitt U
    J Alzheimers Dis; 2009; 16(2):309-14. PubMed ID: 19221420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The novel beta-secretase inhibitor KMI-429 reduces amyloid beta peptide production in amyloid precursor protein transgenic and wild-type mice.
    Asai M; Hattori C; Iwata N; Saido TC; Sasagawa N; Szabó B; Hashimoto Y; Maruyama K; Tanuma S; Kiso Y; Ishiura S
    J Neurochem; 2006 Jan; 96(2):533-40. PubMed ID: 16336629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gallic acid is a dual α/β-secretase modulator that reverses cognitive impairment and remediates pathology in Alzheimer mice.
    Mori T; Koyama N; Yokoo T; Segawa T; Maeda M; Sawmiller D; Tan J; Town T
    J Biol Chem; 2020 Nov; 295(48):16251-16266. PubMed ID: 32913125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BACE/APPV717F double-transgenic mice develop cerebral amyloidosis and inflammation.
    Ozmen L; Woolley M; Albientz A; Miss MT; Nelboeck P; Malherbe P; Czech C; Gruninger-Leitch F; Brockhaus M; Ballard T; Jacobsen H
    Neurodegener Dis; 2005; 2(6):284-98. PubMed ID: 16909011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.
    Obregon DF; Rezai-Zadeh K; Bai Y; Sun N; Hou H; Ehrhart J; Zeng J; Mori T; Arendash GW; Shytle D; Town T; Tan J
    J Biol Chem; 2006 Jun; 281(24):16419-27. PubMed ID: 16624814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting ADAM10 to lipid rafts in neuroblastoma SH-SY5Y cells impairs amyloidogenic processing of the amyloid precursor protein.
    Harris B; Pereira I; Parkin E
    Brain Res; 2009 Nov; 1296():203-15. PubMed ID: 19679113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BACE overexpression alters the subcellular processing of APP and inhibits Abeta deposition in vivo.
    Lee EB; Zhang B; Liu K; Greenbaum EA; Doms RW; Trojanowski JQ; Lee VM
    J Cell Biol; 2005 Jan; 168(2):291-302. PubMed ID: 15642747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-secretase activation--an approach to Alzheimer's disease therapy.
    Fahrenholz F; Postina R
    Neurodegener Dis; 2006; 3(4-5):255-61. PubMed ID: 17047365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease.
    Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM
    FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of Alzheimer's amyloid precursor protein by alpha-secretase occurs at the surface of neuronal cells.
    Parvathy S; Hussain I; Karran EH; Turner AJ; Hooper NM
    Biochemistry; 1999 Jul; 38(30):9728-34. PubMed ID: 10423252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-dependent differential expression of BACE splice variants in brain regions of tg2576 mice.
    Zohar O; Pick CG; Cavallaro S; Chapman J; Katzav A; Milman A; Alkon DL
    Neurobiol Aging; 2005; 26(8):1167-75. PubMed ID: 15917100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of βsheet blocking peptide H102 on APP metabolic enzymes in hippocampal brain of double transgenic AD mice].
    Jiang F; Sun FX; Xu SM
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Apr; 33(4):299-303. PubMed ID: 29926633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model.
    Singer O; Marr RA; Rockenstein E; Crews L; Coufal NG; Gage FH; Verma IM; Masliah E
    Nat Neurosci; 2005 Oct; 8(10):1343-9. PubMed ID: 16136043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.